Choose your location to get a site experience tailored for you.

Remember my region and language settings

Lin Wai Hung is active in the Health Care practice area at Boston Consulting Group, focusing on all aspects of business strategy in that sector. He is based in the San Francisco office, but is currently working out of BCG’s New York office, serving as an Ambassador to BCG Henderson Institute. In this capacity, he is addressing and developing frameworks and future thinking for organizations to navigate complex and changing business environments.

Lin’s recent client work with pharmaceutical companies has included developing an oncology market access strategy based on assessments of future clinical and market access scenarios for breakthrough, but high-cost oncology therapies. He also has developed a digital autism therapy platform for a large pharmaceutical company. In addition, Lin has identified go-to-market launch strategies for new therapeutic agents in retail optometry.

Lin is also active in the media and entertainment and technology sectors, having designed and supported the transformation of a music streaming company in North America. Similarly, he has evaluated total shareholder return (TSR) for a large networking company and developed strategic options to improve future investor return.

Areas of Expertise

  • Go-to-market and launch strategy
  • Working capital and cash flow
  • Oncology therapy market strategy
  • Digital therapy platforms
  • Change management
  • Big data and advanced analytics
  • Corporate development and finance strategy
  • Corporate strategy

Education

  • Postdoctoral fellowship, Stanford University
  • PhD, neuroscience, University of Melbourne
  • BiomedSc, honors, pharmacology, University of Melbourne

Honors and Awards

  • Victoria Premier's Award for Health and Medical Research (Commendation)
  • Australian CJ Martin Research Fellowship
  • Dean's Award for Excellence in the PhD Thesis
Experts
Previous Page